Curaleaf Holdings (CURLF) Gains from Investment Securities (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Gains from Investment Securities of $6.7 million in Q4 2024, up 293.67% quarter-over-quarter from $1.7 million in Q3 2024, and down 38.11% on a YoY basis from $10.7 million in Q1 2024.
Curaleaf Holdings (CURLF) Gains from Investment Securities (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $6.7 million for Q4 2024.
- In Q4 2024, Gains from Investment Securities fell 38.11% year-over-year to $6.7 million; the TTM figure through Dec 2024 stood at $39.5 million (up 40.08% YoY), while the FY2025 annual figure was $888000.0, down 76.79% from the prior year.
- Gains from Investment Securities was $6.7 million for Q4 2024 at Curaleaf Holdings, up from $1.7 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $107.6 million in Q3 2023 to a low of -$75.9 million in Q3 2021.
- Historically, Gains from Investment Securities has averaged $14.5 million across 5 years, with a median of $6.7 million in 2024.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities tumbled 815.71% in 2021, then surged 73786.3% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $27.0 million in 2020, then plunged by 110.41% to -$2.8 million in 2021, then surged by 826.43% to $20.4 million in 2022, then tumbled by 47.29% to $10.7 million in 2023, then plunged by 38.11% to $6.7 million in 2024.
- The last three Gains from Investment Securities figures came in at $6.7 million (Q4 2024), $1.7 million (Q3 2024), and $10.7 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.65 Mn |
| Dec 31, 2024 | 6.65 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Dec 31, 2023 | 10.75 Mn |
| Dec 31, 2023 | 10.75 Mn |
| Sep 30, 2023 | 107.58 Mn |
| Sep 30, 2023 | 107.58 Mn |
| Dec 31, 2022 | 20.39 Mn |
| Dec 31, 2022 | 20.39 Mn |
| Sep 30, 2022 | -146,000.00 |
| Sep 30, 2022 | -146,000.00 |
| Dec 31, 2021 | -2.81 Mn |
| Dec 31, 2021 | -2.81 Mn |
| Sep 30, 2021 | -75.91 Mn |
| Sep 30, 2021 | -75.91 Mn |
| Jun 30, 2021 | 82.76 Mn |
| Jun 30, 2021 | 82.76 Mn |
| Mar 31, 2021 | -171,000.00 |
| Mar 31, 2021 | -171,000.00 |